Cholongitas Evangelos, Goulis Ioannis, Ioannidou Maria, Soulaidopoulos Stergios, Chalevas Parthenis, Akriviadis Evangelos
4th Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Medical School Aristotle University of Thessaloniki, 49, Konstantinopoleos Street, 54642, Thessaloniki, Greece.
Hepatol Int. 2017 May;11(3):306-314. doi: 10.1007/s12072-016-9759-9. Epub 2016 Aug 30.
To investigate if urine albumin-to-creatinine ratio (UACR) is associated with the presence of glomerular filtration rate (GFR) <60 mL/min, severity of liver disease and survival in patients with stable decompensated cirrhosis.
We evaluated prospectively 220 patients (73 % male, age 52.8 ± 12 years). In each patient, assessment of GFR was based on chromium-EDTA. Random urine samples were obtained for measurement of UACR.
Thirty-eight patients (17 %, group 1) had UACR ≥30 mg/g and 182 (83 %, group 2) had UACR <30 mg/g. Group 1, compared to group 2 patients, had significantly lower levels of "true" GFR (61 vs. 71 ml/min, p = 0.035). Patients with "true" GFR <60 mL/min (n = 93), compared to those with "true" GFR ≥60 mL/min (n = 127), had higher levels of UACR (16 vs. 11.3 mg/g, p = 0.023). In multivariate analysis, serum creatinine and UACR (ΟR 0.98, 95 % CI 0.95-0.99, p = 0.04) were independently associated with the presence of GFR <60 mL/min. Based on the area under the ROC curves, the best cut-off point for UACR was >16.51 mg/g giving a sensitivity 70 %, specificity 49 %, PPV 68 % and NPV 51 %. During the follow-up period [17 (6-52) months], the patients who died or underwent LT (n = 158), compared to those who remained alive (n = 62), had higher levels of UACR (41 vs. 13 mg/g, p = 0.025). Patients with UACR ≥30 mg/g had worse outcome, compared to those with UACR <30 mg/g (log rank p = 0.053).
We showed for the first time that UACR ≥30 mg/g was associated with more severe liver disease, lower GFR and worse LT-free survival in patients with decompensated cirrhosis. However, further studies are needed to confirm these findings.
探讨尿白蛋白与肌酐比值(UACR)是否与肾小球滤过率(GFR)<60 mL/min的存在、肝病严重程度以及失代偿期肝硬化稳定患者的生存率相关。
我们前瞻性评估了220例患者(73%为男性,年龄52.8±12岁)。对每位患者,基于铬-乙二胺四乙酸评估GFR。采集随机尿样以测量UACR。
38例患者(17%,第1组)UACR≥30 mg/g,182例(83%,第2组)UACR<30 mg/g。与第2组患者相比,第1组患者的“真实”GFR水平显著更低(61 vs. 71 ml/min,p = 0.035)。“真实”GFR<60 mL/min的患者(n = 93)与“真实”GFR≥60 mL/min的患者(n = 127)相比,UACR水平更高(16 vs. 11.3 mg/g,p = 0.023)。在多变量分析中,血清肌酐和UACR(比值比0.98,95%置信区间0.95 - 0.99,p = 0.04)与GFR<60 mL/min的存在独立相关。根据ROC曲线下面积,UACR的最佳截断点>16.51 mg/g,灵敏度为70%,特异性为49%,阳性预测值为68%,阴性预测值为51%。在随访期[17(6 - 52)个月]内,死亡或接受肝移植的患者(n = 158)与存活患者(n = 62)相比,UACR水平更高(41 vs. 13 mg/g,p = 0.025)。UACR≥30 mg/g的患者与UACR<30 mg/g的患者相比,预后更差(对数秩检验p = 0.053)。
我们首次表明,UACR≥30 mg/g与失代偿期肝硬化患者更严重的肝病、更低的GFR以及更差的无肝移植生存率相关。然而,需要进一步研究来证实这些发现。